Affordable Access to Cancer Drugs and Other Lifesaving Medicines in the United States

Ethics in Biology, Engineering and Medicine 9 (1):99-115 (2018)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.1615/ethicsbiologyengmed.2019032845

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,227

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Affordable Access to Cancer and Other Lifesaving Drugs in the United States.Evaristus Obi - forthcoming - Ethics in Biology, Engineering and Medicine: An International Journal.
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine and Ethics 40 (2):234-250.
Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry—Defining the “Goods” at Stake.Narcyz Ghinea, Miles Little & Wendy Lipworth - 2017 - Journal of Bioethical Inquiry 14 (3):401-410.
Evaluating the Usefulness of Compulsory Licensing in Developing Countries: A Comparative Study of Thai and Brazilian Experiences Regarding Access to Aids Treatments.Samira Guennif - 2016 - Developing World Bioethics 17 (2):90-99.
The Affordable Care Act and Recent Reforms: Policy Implications for Equitable Mental Health Care Delivery.Joelle Robertson-Preidler, Manuel Trachsel, Tricia Johnson & Nikola Biller-Andorno - 2020 - Health Care Analysis 28 (3):228-248.
Basic Survival Needs and Access to Medicines – Coming to Grips with TRIPS: Conversion + Calculation.Rudolf V. Van Puymbroeck - 2010 - Journal of Law, Medicine and Ethics 38 (3):520-549.
The High Price of “Free” Trade: U.S. Trade Agreements and Access to Medicines.Ruth Lopert & Deborah Gleeson - 2013 - Journal of Law, Medicine and Ethics 41 (1):199-223.
Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options.Jerome H. Reichman - 2009 - Journal of Law, Medicine and Ethics 37 (2):247-263.
Introduction: Access to Life-Saving Medicines and Intellectual Property Rights.Doris Schroeder - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):277-278.
Industry, innovation and social values.Dr Harvey E. Bale Jr - 2005 - Science and Engineering Ethics 11 (1):31-40.
Patents and access to drugs in developing countries: An ethical analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58–75.
Patents and Access to Drugs in Developing Countries: An Ethical Analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58-75.
Affordable Access to Essential Medication in Developing Countries: Conflicts Between Ethical and Economic Imperatives1.Udo Schüklenk - 2002 - Journal of Medicine and Philosophy 27 (2):179-195.
What Is Fair? Choice, Fairness, and Transparency in Access to Prescription Medicines in the United States and Australia.Ruth Lopert & Sara Rosenbaum - 2007 - Journal of Law, Medicine and Ethics 35 (4):643-656.
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine and Ethics 40 (2):234-250.

Analytics

Added to PP
2022-11-10

Downloads
2 (#1,807,551)

6 months
1 (#1,477,342)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Evaristus Obi
Duquesne University

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references